Atopic dermatitis is a condition that makes your skin red, itchy and prone to infections. It can be treated with special creams for the skin, tablets or injections.
The investigational drug for this study is called benralizumab and given as an injection into the skin.
The purpose of this research project is to measure how safe and effective this medication is in treating participants with atopic dermatitis. Prior research studies in humans have shown that this medication may help control the immune system that is responsible for the signs and symptoms of atopic dermatitis and help achieve disease improvement.